Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Golddetector said it was late last November you know nothing

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Nov 18, 2022 2:23pm

133 Views

Post# 35111170

Golddetector said it was late last November you know nothing

Every time there is any news you give us BS saying the market will react , next week its a label , Health Canada says 120 days to review a label and Guy has 30 days to submit changes or corrections , so don't scam people into DIN soon BS . Pumper know nothing ! DIN not for at least another 4 or 5 months , see you at .015 again soon then .01 .

<< Previous

Bullboard Posts

Next >>

Air Canada stock rises as service from Ottawa grows